Scandinavian Journal of Immunology · 2013 · 36 citations · 23 references
Life SciencesNeurologyNeuroscienceAutoimmunityInflammationNeuroimmunologyAutoimmune Neurological DisordersComplement SystemDemyelinating DiseasesDemyelinating DisordersMultiple SclerosisNeuroinflammationAutoimmune Neurological DiseaseCerebrospinal Fluid SystemImmune-mediated DemyelinationNeuroinflammatory Disease BiomarkersNeurological Disease BiomarkersNeuromyelitis Optica Spectrum Disorder-associated Optic NeuritisTerminal Complement Complex
Neuromyelitis optica (NMO) and multiple sclerosis (MS) are two of the autoimmune inflammatory demyelinating diseases in the central nervous system. Complement is thought to have an important role in pathogenesis of these diseases, especially in NMO. However, the change of terminal complement complex (TCC, C5b-9) in patients with NMO is still unclear. Cerebrospinal fluid (CSF) C3a, C5a, sC5b-9 were measured by enzyme-linked immunosorbent assay in patients with NMO (n = 26), MS (n = 25) and other neurological disease (OND, n = 19). CSF levels of C5a in patients with NMO were higher than patients with OND (P = 0.006). Increased CSF sC5b-9 were found in the patients with NMO compared with patients with MS (P = 0.029) and OND (P = 0.0001). CSF sC5b-9 in patients with MS were also higher than patients with OND (P = 0.030). Patients with NMO revealed a trend to an increased disease disability with increased CSF sC5b-9 during relapse but not in MS (NMO: P = 0.006, MS: P = 0.097). CSF levels of sC5b-9 are increased in patients with NMO and reflect the activation of complement in NMO.
23
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
Chris H. Polman, Stephen C. Reingold, Brenda Banwell et al. · Annals of Neurology · 2011 · 9.8K citations · Full text
Medicine, Neurology, Neuroscience +10
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
Vanda A. Lennon, Dean M. Wingerchuk, Thomas J. Kryzer et al. · The Lancet · 2004 · 3.2K citations
Life Sciences, Immunology, Neurology +14
Revised diagnostic criteria for neuromyelitis optica
Dean M. Wingerchuk, Vanda A. Lennon, Sean J. Pittock et al. · Neurology · 2006 · 2.6K citations · Full text
Medicine, Neurology, Neuropathology +10
A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica
Claudia F. Lucchinetti · Brain · 2002 · 1.2K citations · Full text
Life Sciences, Immunology, Neurology +17
Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis
Tatsuro Misu, Kazuo Fujihara, Akiyoshi Kakita et al. · Brain · 2007 · 610 citations · Full text